genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics. The Preclinical Research Services division provides pre-clinical testing services in the areas of oncology, oncology supportive care, inflammatory bowel disease, leukaemia, gastrointestinal disease, inflammation, skin care and wound healing, and rheumatoid arthritis.
Read More…
Industry, Sector and Symbol
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-161-9890245
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£2.14 million
Profitability
Miscellaneous
Employees72
Next Earnings DateN/A
OptionableNot Optionable
Genedrive (LON:GDR) Frequently Asked Questions
What is Genedrive's stock symbol?
Genedrive trades on the London Stock Exchange (LON) under the ticker symbol "GDR."
How were Genedrive's earnings last quarter?
Genedrive PLC (LON:GDR) released its quarterly earnings results on Tuesday, March, 20th. The company reported ($9.00) EPS for the quarter. The company earned $2.63 million during the quarter. View Genedrive's Earnings History.
What is the consensus analysts' recommendation for Genedrive?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genedrive in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Genedrive.
Has Genedrive been receiving favorable news coverage?
Media headlines about GDR stock have been trending somewhat negative recently, according to InfoTrie. The research firm scores the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Genedrive earned a media sentiment score of -1.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Genedrive.
Who are some of Genedrive's key competitors?
Some companies that are related to Genedrive include Deepmatter Group (DMTR), SQI Diagnostics (SQD), Imagion Biosys (IBX), LED Medical Diagnostics (LMD), Dorsavi (DVL), Cambridge Cognition (COG), VentriPoint Diagnostics (VPT), Lifespot Health (LSH), Smiles Inclusive (SIL), Cryosite (CTE), 3D Signatures (DXD), Imaging Dynamics (IDL), Med Biogene (MBI), BioMark Diagnostics (BUX) and Carl Data Solutions (CRL).
What other stocks do shareholders of Genedrive own?
Who are Genedrive's key executives?
Genedrive's management team includes the folowing people:
- Mr. David Budd, CEO & Director (Age 51)
- Mr. Matthew J. Fowler, CFO, Company Sec. & Director (Age 44)
How do I buy shares of Genedrive?
Shares of GDR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Genedrive's stock price today?
One share of GDR stock can currently be purchased for approximately GBX 17.
How big of a company is Genedrive?
What is Genedrive's official website?
How can I contact Genedrive?
Genedrive's mailing address is 48 Grafton Street, MANCHESTER, M13 9XX, United Kingdom. The company can be reached via phone at +44-161-9890245.
MarketBeat Community Rating for Genedrive (LON GDR)
MarketBeat's community ratings are surveys of what our community members think about Genedrive and other stocks. Vote "Outperform" if you believe GDR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GDR will underperform the S&P 500 over the long term. You may vote once every thirty days.
